Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIV DNA vaccine - University of Oxford

Next Previous
X
Search
Drug Profile

HIV DNA vaccine - University of Oxford

Alternative Names: DNA.MVA vaccine; HIV-1 gag polyepitope/Modified vaccinia virus Ankara vaccine; HIVA.MVA vaccine; Modified vaccinia virus Ankara/HIV-1 gag polyepitope vaccine; MVA vaccine; MVA.HIVA vaccine

Latest Information Update: 31 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Nairobi; University of Oxford
  • Class AIDS vaccines; DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 28 Aug 2006 Discontinued - Phase-I for HIV infections treatment in United Kingdom (Intradermal)
  • 10 Mar 2005 Data presented at the 12th Conference on Retroviruses and Opportunistic Infections (CROI-2005) have been added to the adverse events and Viral Infections immunogenicity section
  • 22 Feb 2005 Phase-I clinical trials in HIV infections treatment in United Kingdom (Intradermal)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top